🔎 Trials Near Me

Gara Jalqabaatti › Melanoma Uveal › Pennsylvania › Philadelphia

Qorannoo klinikaalii Melanoma Uveal Philadelphia, PA keessatti

Qorannoo 7 Melanoma Uveal f Philadelphia fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 3
  • Wills Eye Hospital at Thomas Jefferson University, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07804186

Tebentafusp-tebn With LDT in Metastatic UM

Namoota walitti qabaa jiraSadarkaa 1/2
  • Thomas Jefferson University, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ado-2026 · NCT06626516

Neoadjuvant Tebentafusp for Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 2
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Wax-2026 · NCT06414590

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT03947385

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Cam-2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 3
  • Jefferson Health Honickman Center, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • Thomas Jefferson University, Philadelphia
Umuriin hundi · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06581406

Qorannoo Melanoma Uveal magaalota biroo keessatti

Qorannoo biroo Philadelphia keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.